Professor Christopher Pepper
Prosiectau fel Prif Ymchwiliwr
- A phase II trial of cyclosporine A in early adverse risk CLL (CyCLL) (01.10.2013 - 30.09.2015)
- BTK inhibition in the dynamic circulating system (01.11.2013 - 31.10.2016)
- Characterisation and targeting of the CD38 axix in chronic lymphocytic leukaemia (08.11.2010 - 30.11.2013)
- Developing novel agents for targeting multiple myeloma (01.10.2013 - 30.09.2016)
- Development of a novel, physiologically relevant, in vitro model of multiple myeloma plasma cell homing to bone marrow (01.10.2016 - 31.10.2019)
Prosiectau fel Cyd-Ymchwiliwr
- Breaking T cell tolerance in chronic lymphocytic leukaemia (01.02.2010 - 01.02.2013)
- Cancer Genetics Biomedical Research Unit (31.03.2011 - 31.05.2015)
- Cardiff Experimental Cancer Medicine Centre (01.04.2012 - 31.03.2017)
- Caveolin-1 is a key determinant of the stem-like features of RCC (01.10.2011 - 31.12.2014)
- Characterisation of the functional role of CD38 in chronic lymphocytic leukaemia by lentiviral infection of primary leukaemic cells 1 (01.01.2008 - 31.03.2011)